These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20231200)

  • 1. Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response.
    Scarsi M; Ziglioli T; Airò P
    J Rheumatol; 2010 May; 37(5):911-6. PubMed ID: 20231200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis.
    Scarsi M; Ziglioli T; Airo' P
    J Rheumatol; 2011 Oct; 38(10):2105-11. PubMed ID: 21807779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept.
    Gómez-García L; Ramírez-Assad C; Vargas A; Massó F; Sánchez-Muñoz F; Márquez-Velasco R; Amezcua-Guerra LM; Bojalil R
    Int J Rheum Dis; 2013 Aug; 16(4):469-71. PubMed ID: 23992270
    [No Abstract]   [Full Text] [Related]  

  • 5. CD45RA-Foxp3(low) non-regulatory T cells in the CCR7-CD45RA-CD27+CD28+ effector memory subset are increased in synovial fluid from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Nishimura K; Miura Y; Kurosaka M; Kumagai S; Morinobu A
    Cell Immunol; 2014 Jul; 290(1):96-101. PubMed ID: 24952375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28nullCD4+ T cells--characterization of an effector memory T-cell population in patients with rheumatoid arthritis.
    Fasth AE; Cao D; van Vollenhoven R; Trollmo C; Malmström V
    Scand J Immunol; 2004; 60(1-2):199-208. PubMed ID: 15238090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis.
    Hooper M; Kallas EG; Coffin D; Campbell D; Evans TG; Looney RJ
    J Rheumatol; 1999 Jul; 26(7):1452-7. PubMed ID: 10405929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis.
    Scarsi M; Paolini L; Ricotta D; Pedrini A; Piantoni S; Caimi L; Tincani A; Airò P
    J Rheumatol; 2014 Apr; 41(4):666-72. PubMed ID: 24584924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.
    Fukuyo S; Nakayamada S; Iwata S; Kubo S; Saito K; Tanaka Y
    Clin Exp Rheumatol; 2017; 35(4):562-570. PubMed ID: 28516880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritis.
    Scarsi M; Zanotti C; Chiarini M; Imberti L; Piantoni S; Frassi M; Tincani A; Airò P
    Clin Exp Rheumatol; 2014; 32(2):204-10. PubMed ID: 24428959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.
    Verburg RJ; Flierman R; Sont JK; Ponchel F; van Dreunen L; Levarht EW; Welling MM; Toes RE; Isaacs JD; van Laar JM
    Ann Rheum Dis; 2005 Oct; 64(10):1397-405. PubMed ID: 15829573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
    Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
    Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept.
    Colombo E; Scarsi M; Piantoni S; Tincani A; Airò P
    Clin Exp Rheumatol; 2016; 34(1):37-41. PubMed ID: 26633185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
    Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M
    Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.
    Fekete A; Soos L; Szekanecz Z; Szabo Z; Szodoray P; Barath S; Lakos G
    J Autoimmun; 2007; 29(2-3):154-63. PubMed ID: 17826949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of abatacept in the management of rheumatoid arthritis.
    Nogid A; Pham DQ
    Clin Ther; 2006 Nov; 28(11):1764-78. PubMed ID: 17212998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis.
    Zhang X; Nakajima T; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2005 Dec; 52(12):3839-49. PubMed ID: 16329093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Brzosko M; Masiuk M; Machalinski B; Gawronska-Szklarz B
    Arthritis Res Ther; 2003; 5(4):R210-3. PubMed ID: 12823856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
    Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.